flag peptide has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 1 studies
| Studies (flag peptide) | Trials (flag peptide) | Recent Studies (post-2010) (flag peptide) | Studies (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid) | Trials (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid) | Recent Studies (post-2010) (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid) |
|---|---|---|---|---|---|
| 544 | 1 | 107 | 792 | 16 | 476 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castillo-Muzquiz, A; Hanaoka, K; Kodadek, T; Lubag, AJ; Sherry, AD | 1 |
1 other study(ies) available for flag peptide and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
| Article | Year |
|---|---|
The detection limit of a Gd3+-based T1 agent is substantially reduced when targeted to a protein microdomain.
Topics: Contrast Media; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Molecular Structure; Molecular Weight; Oligopeptides; Organometallic Compounds; Peptides; Succinimides | 2008 |